Global Rosuvastatin Market Size, Share, and COVID-19 Impact Analysis, By Formulation Type (Injectables, Tablets, and Oral Suspension), By Dose Strength (5mg, 10mg, 20mg, and 40mg), By Indication (Cardiovascular Disease, Atherosclerosis, and Hyperlipidemia), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Feb 2025
REPORT ID SI8060
PAGES 220
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Formulation Type
      2. Market Attractiveness Analysis By Dose Strength
      3. Market Attractiveness Analysis By Indication
      4. Market Attractiveness Analysis By Distribution Channel
      5. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. One of the main factors driving the rosuvastatin market is the geriatric population, which is at a higher risk of developing chronic illnesses as wear and tear of the arteries and blood vessels occurs. 
    3. Restraints
      1.  Reducing brand-name revenue and affecting market dynamics due to reimbursement policy variations.
    4. Opportunities
      1.  The increasing incidence of CVDs globally is a significant driver for the rosuvastatin market.
    5. Challenges
      1. Generics might not always offer the same level of patient trust or adherence, as some patients may prefer the original branded version due to perceived higher quality.
  6. Global Rosuvastatin Market Analysis and Projection, By Formulation Type
    1. Segment Overview
    2. Injectables
    3. Tablets
    4. Oral Suspension
  7. Global Rosuvastatin Market Analysis and Projection, By Dose Strength
    1. Segment Overview
    2. 5mg
    3. 10mg
    4. 20mg
    5. 40mg
  8. Global Rosuvastatin Market Analysis and Projection, By Indication
    1. Segment Overview
    2. Cardiovascular Disease
    3. Atherosclerosis
    4. Hyperlipidemia
  9. Global Rosuvastatin Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Retail Pharmacy
    3. Hospital Pharmacy
    4. Online Pharmacy
  10. Global Rosuvastatin Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  11. Global Rosuvastatin Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Rosuvastatin Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  12. Company Profiles
    1. Lunan Pharmaceutical
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Teva Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Niksan Pharmaceutical 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   JB Pharma 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   MSN Laboratories 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Glenmark Pharmaceuticals Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Nextwell Pharmaceutical
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Pfizer
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Torrent Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Mylan Laboratories 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Lupin Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Sun Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Hikma Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  2. Global Injectables, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  3. Global Tablets, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  4. Global Oral Suspension, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  5. Global Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  6. Global 5mg, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  7. Global 10mg, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  8. Global 20mg, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  9. Global 40mg, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  10. Global Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  11. Global Cardiovascular Disease, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  12. Global Atherosclerosis, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  13. Global Hyperlipidemia, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  14. Global Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  15. Global Retail Pharmacy, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  16. Global Hospital Pharmacy, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  17. Global Online Pharmacy, Rosuvastatin Market, By Region, 2024-2034(USD Billion)
  18. North America Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  19. North America Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  20. North America Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  21. North America Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  22. U.S.  Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  23. U.S.  Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  24. U.S.  Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  25. U.S.  Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  26. Canada Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  27. Canada Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  28. Canada Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  29. Canada Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  30. Mexico Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  31. Mexico Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  32. Mexico Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  33. Mexico Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  34. Europe Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  35. Europe Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  36. Europe Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  37. Europe Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  38. Germany Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  39. Germany Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  40. Germany Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  41. Germany Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  42. France Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  43. France Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  44. France Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  45. France Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  46. U.K.  Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  47. U.K.  Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  48. U.K.  Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  49. U.K.  Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  50. Italy Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  51. Italy Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  52. Italy Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  53. Italy Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  54. Spain Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  55. Spain Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  56. Spain Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  57. Spain Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  58. Asia Pacific Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  59. Asia Pacific Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  60. Asia Pacific Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  61. Asia Pacific Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  62. Japan Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  63. Japan Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  64. Japan Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  65. Japan Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  66. China Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  67. China Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  68. China Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  69. China Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  70. India Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  71. India Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  72. India Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  73. India Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  74. South America Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  75. South America Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  76. South America Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  77. South America Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  78. Brazil Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  79. Brazil Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  80. Brazil Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  81. Brazil Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  82. The Middle East and Africa Rosuvastatin Market, By Formulation Type, 2024-2034(USD   Billion)
  83. The Middle East and Africa Rosuvastatin Market, By Dose Strength, 2024-2034(USD   Billion)
  84. The Middle East and Africa Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  85. The Middle East and Africa Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)
  86. UAE Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  87. UAE Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  88. UAE Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  89. UAE Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion) 
  90. South Africa Rosuvastatin Market, By Formulation Type, 2024-2034(USD Billion)
  91. South Africa Rosuvastatin Market, By Dose Strength, 2024-2034(USD Billion)
  92. South Africa Rosuvastatin Market, By Indication, 2024-2034(USD Billion)
  93. South Africa Rosuvastatin Market, By Distribution Channel, 2024-2034(USD Billion)

List of Figures 

  1. Global Rosuvastatin Market Segmentation
  2. Rosuvastatin Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Rosuvastatin Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Rosuvastatin Market
  20. Rosuvastatin Market Segmentation, By Formulation Type
  21. Rosuvastatin Market For Injectables, By Region, 2024-2034 ($ Billion)
  22.  Rosuvastatin Market For Tablets, By Region, 2024-2034 ($ Billion)
  23. Rosuvastatin Market For Oral Suspension, By Region, 2024-2034 ($ Billion)
  24. Rosuvastatin Market Segmentation, By Dose Strength
  25.  Rosuvastatin Market For 5mg, By Region, 2024-2034 ($ Billion)
  26.  Rosuvastatin Market For 10mg, By Region, 2024-2034 ($ Billion)
  27. Rosuvastatin Market For 20mg, By Region, 2024-2034 ($ Billion)
  28. Rosuvastatin Market For 40mg, By Region, 2024-2034 ($ Billion)
  29. Rosuvastatin Market Segmentation, By Indication
  30. Rosuvastatin Market For Cardiovascular Disease, By Region, 2024-2034 ($ Billion)
  31. Rosuvastatin Market For Atherosclerosis, By Region, 2024-2034 ($ Billion)
  32. Rosuvastatin Market For Hyperlipidemia, By Region, 2024-2034 ($ Billion)
  33. Rosuvastatin Market Segmentation, By Distribution Channel
  34. Rosuvastatin Market For Retail Pharmacy, By Region, 2024-2034 ($ Billion)
  35. Rosuvastatin Market For Hospital Pharmacy, By Region, 2024-2034 ($ Billion)
  36. Rosuvastatin Market For Online Pharmacy, By Region, 2024-2034 ($ Billion)
  37. Lunan Pharmaceutical: Net Sales, 2024-2034 ($ Billion)
  38. Lunan Pharmaceutical: Revenue Share, By Segment, 2024 (%)
  39. Lunan Pharmaceutical: Revenue Share, By Region, 2024 (%)
  40. Teva Pharmaceuticals: Net Sales, 2024-2034 ($ Billion)
  41. Teva Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  42. Teva Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  43. Niksan Pharmaceutical: Net Sales, 2024-2034 ($ Billion)
  44. Niksan Pharmaceutical: Revenue Share, By Segment, 2024 (%)
  45. Niksan Pharmaceutical: Revenue Share, By Region, 2024 (%)
  46. JB Pharma: Net Sales, 2024-2034 ($ Billion)
  47. JB Pharma: Revenue Share, By Segment, 2024 (%)
  48. JB Pharma: Revenue Share, By Region, 2024 (%)
  49. MSN Laboratories: Net Sales, 2024-2034 ($ Billion)
  50. MSN Laboratories: Revenue Share, By Segment, 2024 (%)
  51. MSN Laboratories: Revenue Share, By Region, 2024 (%)
  52. Glenmark Pharmaceuticals Inc.: Net Sales, 2024-2034 ($ Billion)
  53. Glenmark Pharmaceuticals Inc.: Revenue Share, By Segment, 2024 (%)
  54. Glenmark Pharmaceuticals Inc.: Revenue Share, By Region, 2024 (%)
  55. Nextwell Pharmaceutical: Net Sales, 2024-2034 ($ Billion)
  56. Nextwell Pharmaceutical: Revenue Share, By Segment, 2024 (%)
  57. Nextwell Pharmaceutical: Revenue Share, By Region, 2024 (%)
  58. Pfizer: Net Sales, 2024-2034 ($ Billion)
  59. Pfizer: Revenue Share, By Segment, 2024 (%)
  60. Pfizer: Revenue Share, By Region, 2024 (%)
  61. Torrent Pharmaceuticals.: Net Sales, 2024-2034 ($ Billion)
  62. Torrent Pharmaceuticals.: Revenue Share, By Segment, 2024 (%)
  63. Torrent Pharmaceuticals.: Revenue Share, By Region, 2024 (%)
  64. Mylan Laboratories: Net Sales, 2024-2034 ($ Billion)
  65. Mylan Laboratories: Revenue Share, By Segment, 2024 (%)
  66. Mylan Laboratories: Revenue Share, By Region, 2024 (%)
  67. Lupin Pharmaceuticals: Net Sales, 2024-2034 ($ Billion)
  68. Lupin Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  69. Lupin Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  70. Sun Pharmaceuticals: Net Sales, 2024-2034 ($ Billion)
  71. Sun Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  72. Sun Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  73. Hikma Pharmaceuticals: Net Sales, 2024-2034 ($ Billion)
  74. Hikma Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  75. Hikma Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  76. Others: Net Sales, 2024-2034 ($ Billion)
  77. Others: Revenue Share, By Segment, 2024 (%)
  78. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:113
Pages:220
Countries covered:17
Companies covered::19
Forecast CAGR:3.80%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies